Literature DB >> 26246408

Deep brain stimulation in mental health: Review of evidence for clinical efficacy.

Paul B Fitzgerald1, Rebecca A Segrave2.   

Abstract

OBJECTIVE: There is increasing interest in the use of deep brain stimulation as a treatment for psychiatric disorders. In this review, we consider the evidence for the effectiveness of deep brain stimulation for psychiatric indications, with a primary focus on obsessive compulsive disorder and major depressive disorder.
METHODS: Case reports, case series and clinical trials where deep brain stimulation was primarily utilised in the treatment of a psychiatric disorder, including obsessive compulsive disorder, major depressive disorder, anorexia nervosa or an addictive disorder were identified. The evidence for the effectiveness of deep brain stimulation in the treatment of obsessive compulsive disorder and major depressive disorder was reviewed with studies clustered by the site of implantation.
RESULTS: The majority of identified manuscripts report small case series or single cases. A limited number of studies have reported some form of randomised or blinded stimulation comparison. All of these comparative reports have included small samples of subjects (less than 20 per study in total) compromising the feasibility of making statistical comparison between outcomes in the comparison phases. The two exceptions to this have been industry-sponsored studies conducted in the treatment of major depressive disorder. However, both were stopped prematurely due to concerns about poor efficacy.
CONCLUSIONS: There is insufficient evidence at this point in time to support the use of deep brain stimulation as a clinical treatment for any psychiatric disorder outside of research and programmes where formal outcome data are being systematically collated. While some promising initial data exist to support its potential efficacy for a number of psychiatric conditions, further research is required to establish optimal implantation targets, patient characteristics associated with positive therapeutic outcomes and optimal deep brain stimulation parameters and parameter-programming methods. © The Royal Australian and New Zealand College of Psychiatrists 2015.

Entities:  

Keywords:  Deep brain stimulation; depression; obsessive compulsive disorder; psychosurgery; treatment resistance

Mesh:

Year:  2015        PMID: 26246408     DOI: 10.1177/0004867415598011

Source DB:  PubMed          Journal:  Aust N Z J Psychiatry        ISSN: 0004-8674            Impact factor:   5.744


  6 in total

Review 1.  The Role of Psychotropic Medications in the Management of Anorexia Nervosa: Rationale, Evidence and Future Prospects.

Authors:  Guido K W Frank; Megan E Shott
Journal:  CNS Drugs       Date:  2016-05       Impact factor: 5.749

Review 2.  Biomarkers for Deep Brain Stimulation in Animal Models of Depression.

Authors:  Jason Yuen; Aaron E Rusheen; Joshua Blair Price; Abhijeet S Barath; Hojin Shin; Abbas Z Kouzani; Michael Berk; Charles D Blaha; Kendall H Lee; Yoonbae Oh
Journal:  Neuromodulation       Date:  2022-02

Review 3.  A review of brain stimulation methods to treat substance use disorders.

Authors:  Alexandria S Coles; Karolina Kozak; Tony P George
Journal:  Am J Addict       Date:  2018-02-19

4.  Neurotechnology: Current Developments and Ethical Issues.

Authors:  Oliver Müller; Stefan Rotter
Journal:  Front Syst Neurosci       Date:  2017-12-13

Review 5.  Deep brain stimulation in the treatment of obsessive-compulsive disorder: current perspectives.

Authors:  Maud Tastevin; Giorgio Spatola; Jean Régis; Christophe Lançon; Raphaëlle Richieri
Journal:  Neuropsychiatr Dis Treat       Date:  2019-05-15       Impact factor: 2.570

Review 6.  Biomarkers for Deep Brain Stimulation in Animal Models of Depression.

Authors:  Jason Yuen; Aaron E Rusheen; Joshua Blair Price; Abhijeet S Barath; Hojin Shin; Abbas Z Kouzani; Michael Berk; Charles D Blaha; Kendall H Lee; Yoonbae Oh
Journal:  Neuromodulation       Date:  2021-06-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.